What is the real therapeutic effect of Laos version of capmatinib?
The Lao version of Capmatinib , as a common overseas generic drug, has attracted much attention from patients because of its relatively affordable price and flexible access channels, especially when it is not yet popular in China or the price is high. Most of the generic drugs produced in Laos are handled by multinational pharmaceutical companies or large local pharmaceutical companies, such as Hetero, Lucius, Second Pharma, etc. These manufacturers have international certifications to ensure that their production processes, raw material sources, dissolution curves, etc. are as close as possible to the original drug standards. Taking the packaging of capmatinib 200mg*56 tablets as an example, the current market price in Laos is generally around RMB 2,000, which is about 1/10 of the price of the original drug. It is suitable for patients with heavy long-term treatment burdens.

Judging from the actual therapeutic effect, the main ingredient of the Lao version of capmatinib is the same as the original drug, which is a targeted drug targeting MET exon 14 skipping mutations non-small cell lung cancer (NSCLC). According to information compiled from patient feedback and overseas drug platforms, its efficacy is not essentially different from that of the original drug in terms of controlling tumor progression, shrinking lesions, and relieving respiratory symptoms. Many patients using generic drugs have shown signs of tumor marker decline, imaging stability and even partial remission after taking them for several weeks, which reflects that the bioequivalence of generic drugs is reliable in most cases. Of course, the efficacy depends not only on the drug itself, but also on individual patient factors (such as mutation type, medication compliance, comorbidity management, etc.).
Therefore, when choosing the Lao version of capmatinib, patients should obtain it through formal channels and use it under the guidance of a doctor as much as possible. Patients who intend to purchase medicines overseas should pay special attention to the legality of the source of the medicine, batch number, expiry date, packaging consistency, etc. to prevent counterfeit and shoddy products from affecting the therapeutic effect.
Reference materials:https://www.drugs.com/mtm/capmatinib.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)